AR045236A1 - Conjugados de hidroxialquil almidon y g-csf - Google Patents
Conjugados de hidroxialquil almidon y g-csfInfo
- Publication number
- AR045236A1 AR045236A1 ARP040102852A ARP040102852A AR045236A1 AR 045236 A1 AR045236 A1 AR 045236A1 AR P040102852 A ARP040102852 A AR P040102852A AR P040102852 A ARP040102852 A AR P040102852A AR 045236 A1 AR045236 A1 AR 045236A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- polymer
- aldehyde
- conjugates
- keto
- Prior art date
Links
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 title abstract 2
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 title abstract 2
- 229920000642 polymer Polymers 0.000 abstract 12
- 125000003172 aldehyde group Chemical group 0.000 abstract 7
- 125000000468 ketone group Chemical group 0.000 abstract 6
- 125000000524 functional group Chemical group 0.000 abstract 5
- 238000000034 method Methods 0.000 abstract 5
- 229920002472 Starch Polymers 0.000 abstract 4
- 125000001976 hemiacetal group Chemical group 0.000 abstract 4
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 4
- 102000004169 proteins and genes Human genes 0.000 abstract 4
- 108090000623 proteins and genes Proteins 0.000 abstract 4
- 235000019698 starch Nutrition 0.000 abstract 4
- 239000008107 starch Substances 0.000 abstract 4
- 125000003277 amino group Chemical group 0.000 abstract 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 3
- 125000003396 thiol group Chemical group [H]S* 0.000 abstract 2
- 230000003213 activating effect Effects 0.000 abstract 1
- 230000001588 bifunctional effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000005690 diesters Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 210000003714 granulocyte Anatomy 0.000 abstract 1
- 230000003394 haemopoietic effect Effects 0.000 abstract 1
- 125000005179 haloacetyl group Chemical group 0.000 abstract 1
- 230000036737 immune function Effects 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2003/008858 WO2004024761A1 (en) | 2002-09-11 | 2003-08-08 | Hasylated polypeptides, especially hasylated erythropoietin |
| PCT/EP2003/008859 WO2004024777A1 (en) | 2002-09-11 | 2003-08-08 | Hydroxyalkyl starch derivatives |
| PCT/EP2003/008829 WO2004024776A1 (en) | 2002-09-11 | 2003-08-08 | Method of producing hydroxyalkyl starch derivatives |
| EP04005874 | 2004-03-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR045236A1 true AR045236A1 (es) | 2005-10-19 |
Family
ID=34924483
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP040102852A AR045236A1 (es) | 2003-08-08 | 2004-08-09 | Conjugados de hidroxialquil almidon y g-csf |
Country Status (7)
| Country | Link |
|---|---|
| AR (1) | AR045236A1 (de) |
| AT (1) | ATE493150T1 (de) |
| DE (1) | DE602004030805D1 (de) |
| DK (1) | DK1660134T3 (de) |
| ES (1) | ES2357001T3 (de) |
| SI (1) | SI1660134T1 (de) |
| TW (2) | TWI357337B (de) |
-
2004
- 2004-08-06 TW TW093123553A patent/TWI357337B/zh not_active IP Right Cessation
- 2004-08-06 DE DE602004030805T patent/DE602004030805D1/de not_active Expired - Lifetime
- 2004-08-06 TW TW093123647A patent/TW200519128A/zh unknown
- 2004-08-06 DK DK04763853.1T patent/DK1660134T3/da active
- 2004-08-06 AT AT04763853T patent/ATE493150T1/de active
- 2004-08-06 ES ES04763853T patent/ES2357001T3/es not_active Expired - Lifetime
- 2004-08-06 SI SI200431617T patent/SI1660134T1/sl unknown
- 2004-08-09 AR ARP040102852A patent/AR045236A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2357001T3 (es) | 2011-04-15 |
| SI1660134T1 (sl) | 2011-04-29 |
| TW200519128A (en) | 2005-06-16 |
| DK1660134T3 (da) | 2011-04-04 |
| ATE493150T1 (de) | 2011-01-15 |
| TW200520776A (en) | 2005-07-01 |
| TWI357337B (en) | 2012-02-01 |
| DE602004030805D1 (de) | 2011-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR048035A1 (es) | Conjugados de almidon de hidroxialquilo y una proteina, preparados por aminacion reductora | |
| Zare et al. | Protein-protected metal nanoclusters as diagnostic and therapeutic platforms for biomedical applications | |
| AR045450A1 (es) | Conjugados de almidon de hidroxialquilo y una proteina | |
| WO2004018000A3 (en) | Compositions and methods for treating cancer using maytansinoid cd44 antibody immonoconjugates and chemotherapeutic agents | |
| PT93966A (pt) | Novo sistema de libertacao de anticorpos para modificadores de resposta biologica | |
| ES8101384A1 (es) | Procedimiento de preparacion de productos citotoxicos | |
| WO2003074088A3 (de) | Kopplung niedermolekularer substanzen an hydroxyalkylstärke | |
| AR069903A1 (es) | Conjugado anticuerpo- molecula asociada dirigidos a la proteina tirosina quinasa 7 (ptk 7), composicion farmaceutica que lo comprende, acido nucleico, factor de expresion y celula huesped relacionados y su uso para preparar un medicamento util para el tratamiento o prevencion de cancer | |
| CY1105701T1 (el) | Μεθοδος δια την παρασκευη ενος ενεσιμου φαρμακευτικου σκευασματος | |
| BR0109704A (pt) | Método de tratamento usando conjugados de imunógeno ligando | |
| AR035977A1 (es) | Inmunoconjugados de anticuerpos cd44 citotoxicos. | |
| CO2024006160A2 (es) | Conjugado de anticuerpo bispecífico-fármaco de camptotecina y uso farmacéutico de este | |
| KR870700361A (ko) | 경구적 전달 방법 | |
| OA07388A (fr) | Nouveaux conjugués associant, par liaison convalente, une enzyme et un anticorps et associations médicamenteuses utilisant lesdits conjugués. | |
| EP1430061A4 (de) | Einschlussverbindung mit cucurbiturilderivaten als wirtsmolekül, und diese enthaltende pharmazeutische zusammensetzung | |
| WO2024130161A3 (en) | Novel camptothecin derivatives and conjugates thereof | |
| IL64722A (en) | Immunoglobulin conjugates,their preparation and pharmaceutical compositions containing them | |
| PE20110001A1 (es) | Derivados de taxanos como agentes citotoxicos | |
| Gaál et al. | Low toxicity and high antitumour activity of daunomycin by conjugation to an immunopotential amphoteric branched polypeptide | |
| EP1368061A4 (de) | Fusionszellen und zytokin-zusammensetzungen zur behandlung von krankheiten | |
| ATE191852T1 (de) | Photodynamische konjugate mit biozide eigenschaften | |
| KR830002510A (ko) | 생물학적 활성화합물과 하이드록시알킬 전분으로 구성되는 조성물 | |
| AR045236A1 (es) | Conjugados de hidroxialquil almidon y g-csf | |
| WO2005025623A3 (en) | Ef-24-factor vii conjugates | |
| IL79260A (en) | Process and composition for activation of immune response cells to be used in the treatment of cancer,non-malignant tumors,infections,and immune deficiencies |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |